Panacos Pharmaceuticals (PANC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Panacos Pharmaceuticals (PANC)

An SI Board Since November 2005

Posts	SubjectMarks	Bans
53	7	0

Emcee: tuck	Type: Unmoderated

Introduction Compact

Panacos is developing small-molecule antivirals. Their lead compound is a first in class, orally available HIV maturation inhibitor. It is heading for PIIb in early 2006. There are other drugs in the pipeline, though they are quite early:

panacos.com

Thus PA-457 will drive interest for some time to come. Here's a couple of snips from their most recent quarterly PR:

"The company recently announced positive results from a Phase 2a study of its lead product candidate, PA-457, a first-in-class HIV maturation inhibitor. The trial met its primary endpoint by demonstrating a statistically significant reduction (p<0.0001) in the level of HIV in the blood, known as viral load, compared to placebo, with a median viral load reduction in the highest dose group of 1.03 log10, or a 91% decrease."

"The company recently completed a common stock offering of 8.25 million shares, with approximately $81.0 million in net proceeds to the Company. These funds, together with existing cash and cash equivalents, should be sufficient to enable Panacos to fund operations into the second half of 2007.<<

Panacos went public earlier this year through a reverse merger with V.I. Technologies. The former's programs are gone; it's all Panacos now.

Link to management team, sans biographies:

panacos.com

This forum is for polite discussion of Panacos and it products, as well as competitors to the extent that they affect Panacos.

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
53	>>Panacos Announces Preliminary Results of Bevirimat Study 204 Monday Octo	tuck	-	10/27/2008
52	>>Panacos Reports Second Quarter 2008 Financial Results Wednesday July 30,	tuck	-	7/30/2008
51	[The absorption, distribution, metabolism and elimination of bevirimat in rats]	tuck	-	7/11/2008
50	They have correlated viral load reductions on bevirimat with polymorphisms withi	idos	-	3/5/2008
49	>>Bevirimat Data Presented at 15th Conference on Retroviruses and Opportun	tuck	-	2/6/2008
48	Panacos has until the 28th of July to regain NASDAQ listing compliance. Cheers,	tuck	-	1/30/2008
47	Still there - why I have to assume PANC should sell. They have gone straight do	Robohogs	-	12/28/2007
46	What happened to the oral fuzeon? That could be worth buying out panc for, but m	rkrw	-	12/28/2007
45	Lowered target to 3 from 7.40, cut estimates dramatically (half the addressable	Robohogs	-	12/27/2007
44	>>Stock Rating Reiterations Closing Update: PANC Last update: 12/27/2007 4	tuck	-	12/27/2007
43	PANC is currently analyzing possible correlations between factors such as protei	idos	-	12/12/2007
42	"We believe there is a population of HIV patients that responds very well t	kenhott	-	12/12/2007
41	[PANC: "We believe there is a population of HIV patients that responds very	idos	-	12/11/2007
40	<So the 300mg cohort results look solid, good> Agreed: There were no serio	idos	-	10/26/2007
39	>>Panacos Reports Third Quarter 2007 Financial Results Thursday October 25	tuck	-	10/25/2007
38	>>Panacos Reports Third Quarter 2007 Financial Results Thursday October 25	tuck	-	10/25/2007
37	The pushout news was known a few days ago or late last week, forget which. SO t	Robohogs	-	9/26/2007
36	The data from the 300mg cohort was supposed to be here by now, so this is a bit	tuck	-	9/26/2007
35	But CFO Marshall has lost the faith: >>Panacos Announces Management Chang	tuck	-	9/24/2007
34	Four weeks ago, CEO Dutton bought 10,000 shares for about $25,000. Good to see	tuck	-	8/30/2007
33	Hmm. Digging a little farther into the CC, I see they are still slow on the ora	tuck	-	8/1/2007
32	>>Panacos Reports Second Quarter 2007 Financial Results Tuesday July 31, 4	tuck	-	7/31/2007
31	Street Pulse: Panacos takes on HIV WASHINGTON, June 29 (UPI) -- United Press In	valuefinder	-	6/30/2007
30	>>On June 28, 2007, Panacos Pharmaceuticals, Inc. entered into a $20 milli	tuck	-	6/29/2007
29	Nice spec in my book - wish I was in so low. Jon	Robohogs	-	6/29/2007

Go to reply# or date (mm/dd/yy):